Problems of Vaccinal Prevention in Adult Population

Брико, Н. И.; Tsapkova, N. N.; Батыршина, Л. Р.; Korshunov, Vladimir Andreevich; Фельдблюм, И. В.; Bikmieva, A. V.; Субботина, К. А.; Филиппов, О. В.

doi:10.31631/2073-3046-2018-17-2-4-15

Cited by 8 publications

(3 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At the first stage of the study, the analysis of incidence for the development of PI in risk groups among the adult population of the Astrakhan region for the pe- 5 Order of the Ministry of Health No. 125n, dated 21 March 2014 "On the approval of the national calendar of preventive vaccinations and the calendar of preventive vaccinations for epidemic indications "with amendments to Appendices No.…”

Section: Resultsmentioning

confidence: 99%

“…The basic prophylactic medical examination documentation submitted by medical institutions, was studied (Form No. 030 / "Dispensary Monitoring Checklist", lists of persons subjected to medical observation in the reporting year) 3,4 Implementation of prophylactic measures in medical organizations was evaluated in accordance with the national calendar of preventive vaccinations 5 .…”

Section: Methodsmentioning

confidence: 99%

“…According to various sources, it reaches 14-15% and comprises about 1.5 million people [3]. The most vulnerable categories for the pneumococ-cal infection (PI) development are young children and adults with chronic diseases of the lungs, cardiovascular system, liver, kidneys, diabetes mellitus (DM) and immunodeficiency diseases [4,5]. The studies show that the risk of PI developing is significantly increased in patients with background diseases, aged 50-64 years.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Pharmacoeconomic Evaluation of Anti-Pneumococcal Vaccination in Risk Groups for the Prevention of Community-Acquired Pneumonia Among Adults in the Astrakhan Region

Орлова

Дорфман

Орлов

et al. 2021

Farm. farmakol. (Pâtigorsk)

View full text Add to dashboard Cite

The aim. To evaluate the economic efficiency and the choice of the vaccination strategy in the respiratory pneumococcal infection risk groups among the adult population of the Astrakhan region.Materials and methods. The data for the period of 2015 - 2018 were analyzed on the number of registered diseases in the patients living in the service area of the medical organizations (Form No. 12, Federal State Statistics Service Orders No. 591, dated 27 November, 2015; No. 679, dated 22 November, 2019). The following working directives were studied: the base medical examination documentation submitted by medical institutions (Form No. 030/y “Dispensary Monitoring Checklist”; lists of the persons subjected to medical observation in the reporting year; Orders of the Ministry of Health of the Russian Federation: No. 1344, dated 12 December, 2012; No. 173n, dated 29 March, 2019). Statistical materials of the territorial fund for compulsory medical insurance of the Astrakhan region on the payment of medical care to 12,970 patients who had had pneumonia in 2015-2018, were analyzed. The financial support of vaccination based on the results of tenders for the procurement of pneumococcal vaccines organized by the regional Ministry of Health, was considered. The calculations were carried out in accordance with the guidelines of “Cost-effectiveness of vaccine prophylaxis” (Methodological guidelines 3.3.1878-04, dated 04.03.2004).Results. The prospective calculation of the vaccination cost showed that the benefits of vaccination with pneumococcal conjugate vaccine Prevenar13 (PCV13) and pneumococcal polyvalent vaccine Pneumovax 23 (PPV23) with a 95% vaccination coverage, are recorded after 2 years. The economic benefit of vaccination by reducing the possible number of pneumonias at the end of 2028 will be 968.2 million rubles.Conclusion. The economic feasibility of vaccine prophylaxis of the adult contingent with an increased risk of developing pneumococcal infection has been established. The sequential strategy of PCV13 and PPV23 application provides the most effective localization of pneumococcal infection. The research results should be widely introduced into the long-term plans for vaccination and healthcare practice in the Astrakhan region.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Pharmacoeconomic Evaluation of Anti-Pneumococcal Vaccination in Risk Groups for the Prevention of Community-Acquired Pneumonia Among Adults in the Astrakhan Region

Орлова

Дорфман

Орлов

et al. 2021

Farm. farmakol. (Pâtigorsk)

View full text Add to dashboard Cite

show abstract

Factors of adherence to vaccination of the Arkhangelsk region adult population

Lopatina,

Nizovtseva,

Kriger

et al. 2024

Rus. J. Prev. Med.

View full text Add to dashboard Cite

The Modern Concept of Development of Vaccine Prevention in Russia

Брико

Фельдблюм

2019

Epidemiology and Vaccinal Prevention

Self Cite

View full text Add to dashboard Cite

2 ФБУН ЦНИИ эпидемиологии Роспотребнадзора 3 ФГБОУ ВО Пермский ГМУ им. академика Е.А. Вагнера Минздрава России Современная концепция развития вакцинопрофилактики в России Резюме Статья посвящена изложению концептуальных основ стратегии развития вакцинопрофилактики в Российской Федерации. Выделены три периода развития вакцинопрофилактики. Положения концепции сформулированы на основе многолетних исследований авторов по проблемам вакцинопрофилактики и анализа данных отечественной и зарубежной научной литературы. Основные положения концепции направлены на: укрепление государственной политики в сфере вакцинопрофилактики как инструмента обеспечения биологической безопасности страны; реконструкцию и расширение отечественного производства вакцин; совершенствование Национального календаря профилактических прививок; продвижение в РФ стратегии ВОЗ «Иммунизация на протяжении жизни»; разработку Национального календаря профилактических прививок для взрослых; дальнейшее развитие региональных основ вакцинопрофилактики; развитие системы мониторинга поствакцинальных осложнений; переход от оценки массовой вакцинопрофилактики по показателям заболеваемости к управлению рисками вакцинопрофилактики; внедрение эпидемиологического надзора за вакцинопрофилактикой как методологии упреждающего воздействия на заболеваемость; обеспечение приверженности населения, медицинских работников, органов законодательной и исполнительной власти, средств массовой информации к вакцинопрофилактике. Реализация положений современной концепции развития вакцинопрофилактики в РФ будет способствовать решению демографических задач, приведет к снижению заболеваемости и смертности населения, обеспечит активное долголетие и значительный экономический эффект.

show abstract

Problems of Vaccinal Prevention in Adult Population

Abstract: The analysis of the vaccine preventive status of infectious diseases in adults in Russia and various countries of the world is presented in the article. The problems and directions of improving the immunization of the adult population in Russia are identified.

Cited by 8 publications

References 23 publications

Pharmacoeconomic Evaluation of Anti-Pneumococcal Vaccination in Risk Groups for the Prevention of Community-Acquired Pneumonia Among Adults in the Astrakhan Region

Pharmacoeconomic Evaluation of Anti-Pneumococcal Vaccination in Risk Groups for the Prevention of Community-Acquired Pneumonia Among Adults in the Astrakhan Region

Factors of adherence to vaccination of the Arkhangelsk region adult population

The Modern Concept of Development of Vaccine Prevention in Russia

Contact Info

Product

Resources

About